Fig. 3.
Brain metastasis progression free survival since the initiation of treatment (n = 96): 54 patients exhibited progressive brain disease after local or systemic treatment. The 2-year brain metastasis progression free survival (BM PFS) was 29.6 %, and the estimated BM PFS time was 17 months